Buy or sell Alumis stock pre IPO via an EquityZen fund
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
About Alumis Stock
Alumis is a precision medicines company looking to eliminate the “all-comers” approach that is seen with today’s treatments for people with autoimmune disease. Even with the innovation of the last decade, many patients continue to cycle through the approved therapies while continuing to look for the right therapy to alleviate the impact of their disease without life-impacting side effects. Esker leverages a precision analytics platform, powered by Foresite Labs, coupled with a team of experts with deep experience in precision medicine drug development and immunology, in order to create medicines that change the lives of people with autoimmune disease.
Board of Directors
Chief Development Officer
Founder, President & CEO
Head of Research
Ken A Brameld
Vice President, Clinical Operations
Senior Vice President, Chief Information Officer